Deepening Collaboration in AI-Powered R&D Acceleration: Insilico Medicine and CMS announce additional collaborations in CNS diseases
SHANGHAI, July 13, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), and China Medical System Holdings Limited ("CMS", 867.HK/8A8.SG), an...
The 4th China International Supply Chain Expo: Healthy Life Chain Unveils Full Spectrum of Global Healthcare Supply Chain Innovation
BEIJING, June 26, 2026 /PRNewswire/ -- The Fourth China International Supply Chain Expo (CISCE) has opened its Healthy Life Chain section, drawing more than 100 leading companies across three core zones—Medical Technology, Quality Living, and...